SLN SCHEDULE 13G/A: SEC filing
A Schedule 13G/A amendment was
Filed with the SEC on · accession 0000919574-26-006906
SLN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 13, 2026. A Schedule 13G/A amendment was filed regarding Silence Therapeutics plc, indicating a change in a passive institutional holder's ownership position. The stock moved -8.1% by the first close after the filing.
Summary of the filing
A Schedule 13G/A amendment was filed regarding Silence Therapeutics plc, indicating a change in a passive institutional holder's ownership position. The filing text provided contains only EDGAR directory metadata and no substantive ownership details.
Key details
How SLN stock reacted
Close before
$9.65
Oct 12, 2026
First close after
-8.08%
$8.87
5 trading days
+102.90%
$19.58
Since filing
+104.46%
$19.73
✦ Ask GOAX AI about this filing — what it means for SLN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLN?
Click hereFrequently asked questions
What did SLN file with the SEC on Oct 13, 2026?
SLN filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding Silence Therapeutics plc, indicating a change in a passive institutional holder's ownership position. The filing text provided contains only EDGAR directory metadata and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did SLN stock react to this filing?
SLN closed at $9.65 before the filing and $8.87 on Oct 13, 2026 (-8.08%). Five trading days later: $19.58 (+102.90%).
Other SLN SEC filings
- 8-K · AcquisitionOct 19, 2026
- 8-K · Secondary offeringAug 12, 2026
- 424B5 · Secondary offeringAug 12, 2026
- 424B5 · Secondary offeringAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · SEC filingAug 10, 2026
- 8-K · Fda approvalAug 10, 2026
- 8-K · SEC filingJul 16, 2026
- 8-K · SEC filingJun 23, 2026
- 8-K · SEC filingJun 16, 2026
Get alerts when SLN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days